10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
August 06 2021 - 8:00AM
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will
be participating in the upcoming UBS Genomics 2.0 and MedTech
Innovations Summit.
10x Genomics’ management is scheduled to present
on Tuesday, August 10th at 6:00 p.m. Eastern Time/3 p.m. Pacific
Time. Interested parties may access a live and archived webcast of
the presentation on the “Investors” section of the company’s
website at: https://investors.10xgenomics.com/.
About 10x Genomics10x Genomics
is a life science technology company building products to
interrogate, understand and master biology to advance human health.
The company’s integrated solutions include instruments, consumables
and software for analyzing biological systems at a resolution and
scale that matches the complexity of biology. 10x Genomics products
have been adopted by researchers around the world including in all
of the top 100 global research institutions as ranked by Nature in
2020 based on publications and all of the top 20 global
pharmaceutical companies by 2020 research and development spend and
have been cited in over 2,800 research papers on discoveries
ranging from oncology to immunology and neuroscience. The company’s
patent portfolio comprises more than 1,150 issued patents and
patent applications.
Disclosure Information10x
Genomics uses filings with the Securities and Exchange Commission,
its website (www.10xgenomics.com), press releases, public
conference calls, public webcasts and its social media accounts as
means of disclosing material non-public information and for
complying with its disclosure obligations under Regulation FD.
ContactsMedia:media@10xgenomics.com
Investors:investors@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024